Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thierry Vander Borght

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|February 2, 2006
Molecular imaging of cell transplantation in Parkinson's diseaseThierry Vander Borght
Movement Disorders : Official Journal of the Movement Disorder Society|October 5, 2007
Accuracy of DaTSCAN (123I-Ioflupane) SPECT in diagnosis of patients with clinically uncertain parkinsonism: 2-year follow-up of an open-label studyEduardo Tolosa, Thierry Vander Borght, Emilio Moreno, et al.
AJNR. American Journal of Neuroradiology|June 16, 2006
Age and gender effects on normal regional cerebral blood flowAnne-Sophie Pirson, Thierry Vander Borght, Koen Van Laere
European Journal of Nuclear Medicine and Molecular Imaging|May 27, 2010
The diagnostic accuracy of 18F-FDG PET in cutaneous malignant melanomaBruno Krug, Anne-Sophie Pirson, Ralph Crott, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 13, 2006
Is a methodology available that accurately measures the cost of an FDG-PET study?Bruno Krug, Anne Sophie Pirson, Ralph Crott, et al.
Clinical Nuclear Medicine|November 6, 2020
Presacral Myelolipoma: The Usefulness of a 99mTc-Albumin Nanocolloid ScintigraphyLaurent Guillaume, Thierry Vander Borght, Claude Bertrand, et al.
Clinical Nuclear Medicine|June 24, 2003
A well-differentiated hepatocellular carcinoma detected only by F-18 FDG positron emission tomographyBruno Krug, Jean-Paul Martinet, Marc Lacrosse, et al.
Health Policy (Amsterdam, Netherlands)|May 19, 2009
Activity-based costing evaluation of a [(18)F]-fludeoxyglucose positron emission tomography studyBruno Krug, Annie Van Zanten, Anne-Sophie Pirson, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|March 19, 2014
A systematic review of the predictive value of (18)FDG-PET in esophageal and esophagogastric junction cancer after neoadjuvant chemoradiation on the survival outcome stratificationPascaline Schollaert, Ralph Crott, Claude Bertrand, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 25, 2007
Activity-based costing evaluation of [18F]-fludeoxyglucose productionBruno Krug, Annie Van Zanten, Anne-Sophie Pirson, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
European Journal of Nuclear Medicine and Molecular Imaging|February 2, 2006
Molecular imaging of cell transplantation in Parkinson's diseaseThierry Vander Borght
Movement Disorders : Official Journal of the Movement Disorder Society|October 5, 2007
Accuracy of DaTSCAN (123I-Ioflupane) SPECT in diagnosis of patients with clinically uncertain parkinsonism: 2-year follow-up of an open-label studyEduardo Tolosa, Thierry Vander Borght, Emilio Moreno, et al.
AJNR. American Journal of Neuroradiology|June 16, 2006
Age and gender effects on normal regional cerebral blood flowAnne-Sophie Pirson, Thierry Vander Borght, Koen Van Laere
European Journal of Nuclear Medicine and Molecular Imaging|May 27, 2010
The diagnostic accuracy of 18F-FDG PET in cutaneous malignant melanomaBruno Krug, Anne-Sophie Pirson, Ralph Crott, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 13, 2006
Is a methodology available that accurately measures the cost of an FDG-PET study?Bruno Krug, Anne Sophie Pirson, Ralph Crott, et al.
Clinical Nuclear Medicine|November 6, 2020
Presacral Myelolipoma: The Usefulness of a 99mTc-Albumin Nanocolloid ScintigraphyLaurent Guillaume, Thierry Vander Borght, Claude Bertrand, et al.
Clinical Nuclear Medicine|June 24, 2003
A well-differentiated hepatocellular carcinoma detected only by F-18 FDG positron emission tomographyBruno Krug, Jean-Paul Martinet, Marc Lacrosse, et al.
Health Policy (Amsterdam, Netherlands)|May 19, 2009
Activity-based costing evaluation of a [(18)F]-fludeoxyglucose positron emission tomography studyBruno Krug, Annie Van Zanten, Anne-Sophie Pirson, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|March 19, 2014
A systematic review of the predictive value of (18)FDG-PET in esophageal and esophagogastric junction cancer after neoadjuvant chemoradiation on the survival outcome stratificationPascaline Schollaert, Ralph Crott, Claude Bertrand, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 25, 2007
Activity-based costing evaluation of [18F]-fludeoxyglucose productionBruno Krug, Annie Van Zanten, Anne-Sophie Pirson, et al.
Pageof 7